Anterix director Yazdi granted 1,598 restricted shares

YAZDI MAHVASH reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

YAZDI MAHVASH reported acquisition or exercise transactions in this Form 4 filing.

Anterix Inc. director Mahvash Yazdi received a grant of 1,598 shares of common stock on August 4, 2026, as a restricted stock award at $0.00 per share. These shares vest on the earlier of the 2027 annual shareholder meeting or August 4, 2027. Following the grant, she directly holds 21,005 shares, with additional indirect holdings of 250 shares through a family trust, where she disclaims beneficial ownership beyond her pecuniary interest, and 750 shares through a 401(k) plan. The transaction is reported as not pursuant to a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 1,598 shares

Grant/Award 3 txns

Insider YAZDI MAHVASH

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	1,598	$0.00	$0.00
holding	Common Stock F2	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 21,005 shares (Direct); Common Stock — 250 shares (Indirect, By Yazdi Family Trust UA Oct 03, 1988); Common Stock — 750 shares (Indirect, By 401(k))

Footnotes (2)

1. F1. The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.
2. F2. Ms. Yazdi is a trustee of the Yazdi Family Trust UA Oct 03, 1998 and has voting and dispositive power with respect to these shares. Ms. Yazdi disclaims beneficial ownership except to the extent of her pecuniary interest therein.

Key Figures

Restricted stock grant: 1,598 shares Grant price: $0.00 per share Direct holdings after grant: 21,005 shares +3 more

6 metrics

Restricted stock grant 1,598 shares Common stock awarded to director Mahvash Yazdi on August 4, 2026

Grant price $0.00 per share Price reported for the 1,598-share restricted stock award

Direct holdings after grant 21,005 shares Total directly held Anterix common shares following the reported grant

Indirect trust holdings 250 shares Indirect holdings via Yazdi family trust, with pecuniary-interest disclaimer

Indirect 401(k) holdings 750 shares Indirect holdings reported as held through a 401(k) plan

Vesting date outside meeting August 4, 2027 Latest vesting date for 1,598 restricted shares if earlier meeting does not occur

Key Terms

Restricted Stock Agreement, voting and dispositive power, pecuniary interest

3 terms

Restricted Stock Agreement financial

"subject to the terms of the Restricted Stock Agreement"

voting and dispositive power financial

"has voting and dispositive power with respect to these shares"

pecuniary interest financial

"disclaims beneficial ownership except to the extent of her pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider stock grant did Anterix (ATEX) report for director Mahvash Yazdi?

Anterix reported that director Mahvash Yazdi received 1,598 shares of common stock as a restricted stock award on August 4, 2026, at $0.00 per share. After this grant, her directly held shares increased to 21,005, plus separately reported indirect holdings.

When will Mahvash Yazdi’s new Anterix (ATEX) restricted shares vest?

The 1,598 restricted shares granted to Mahvash Yazdi will vest on the earlier of the 2027 annual meeting of shareholders or August 4, 2027. Vesting remains subject to the terms of the company’s Restricted Stock Agreement.

How many Anterix (ATEX) shares does Mahvash Yazdi hold after this Form 4?

After the reported grant, Mahvash Yazdi directly holds 21,005 Anterix common shares. She also has indirect interests in 250 shares via a family trust and 750 shares via a 401(k) plan, as disclosed in the ownership tables and footnotes.

Were Mahvash Yazdi’s Anterix (ATEX) share transactions under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox was not checked, meaning the reported grant of 1,598 shares was not affirmatively identified as made under a pre-arranged Rule 10b5-1 trading plan.

How are Mahvash Yazdi’s indirect Anterix (ATEX) holdings structured?

Indirect holdings include 250 shares held by a Yazdi family trust, where she is trustee with voting and dispositive power but disclaims beneficial ownership except for her pecuniary interest, and 750 shares held through a 401(k) plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 10:17 AM Accepted by SEC EDGAR 08/06/2026 - 10:16 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YAZDI MAHVASH

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NEW JERSEY 07424

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		A		1,598(1)	A	$0	21,005	D
Common Stock								250	I	By Yazdi Family Trust UA Oct 03, 1988(2)
Common Stock								750	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, subject to the terms of the Restricted Stock Agreement.

2. Ms. Yazdi is a trustee of the Yazdi Family Trust UA Oct 03, 1998 and has voting and dispositive power with respect to these shares. Ms. Yazdi disclaims beneficial ownership except to the extent of her pecuniary interest therein.

Remarks:

	s/ Gena L. Ashe, Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)